Syntimmune raised $10M Series A Plus venture round, led by David de Graaf.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
BaxaltaLEAD | Private | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$68M
Top Valuation
-
Syntimmune raised $10M in a Series A Plus round.
The round was announced on 03/22/16.
The round was led by David de Graaf, Baxalta Ventures.